A father who went by the alias Li Jun from China’s Gansu province shared how his daughter suffered because of the COVID-19 vaccine. His four-year-old daughter developed a fever and a cough after getting her first COVID-19 vaccine dose in November 2021, but these subsided following intravenous therapy. However, things worsened after Li’s daughter received her second vaccine dose in January.
The child experienced swelling around her eyes, leg pain and bruises at her lower extremities. A few weeks after the second COVID-19 vaccine dose, Li’s daughter was diagnosed with acute lymphoblastic leukemia. She is now undergoing chemotherapy at the Lanzhou No. 2 People’s Hospital in the provincial capital, alongside at least 20 other children who developed identical symptoms.
“My baby was perfectly healthy before the vaccine dose. I took her for a health check, [and] everything was normal,” said Li.
Another father who went by the alias Wang Long said his 10-year-old child was forced to get the COVID-19 vaccine under threat of being barred from attending classes. “The school told us last year to take him for vaccination on such and such date, or he can’t go to class,” the parent from Shandong province remarked.
The 10-year-old received his second COVID-19 vaccine dose on Dec. 4, but experienced fatigue and low fever a month later. He was diagnosed with acute leukemia on Jan. 18 and is now undergoing treatment for the condition at the Qilu Hospital of Shandong University.
“Had he inherited [the leukemia] from the family, we’d accept it as our lot. But he got sick because of the vaccine. I just can’t reconcile it,” Wang commented on his son’s predicament.
Beijing turns a blind eye to vaccine-induced leukemia cases
The leukemia diagnoses of the two children came months after Beijing mandated COVID-19 vaccination for children between three and 11 years old in October 2021. As per the latest data from China’s National Health Commission, about 84.4 million children – more than half of the cohort’s population – have been vaccinated as of Nov. 13, 2021.
Mainland China has used the COVID-19 vaccines from private drug manufacturer Sinovac Biotech and state-owned Sinopharm for children. The Sinopharm shot reported an efficacy rate of 79 percent based on clinical trials on adult participants. Meanwhile, the Sinovac shot reported a lower 50.4 percent efficacy rate during the same trials.
It turns out that Li and Wang were not the only individuals whose children suffered from vaccine damage. Thanks to a group on the Chinese social media platform WeChat, the parent from Gansu province has come to know more than 500 patients and their family members who underwent the same experience of post-vaccination leukemia. Despite assurances by health authorities of a probe of the matter, he and the others remain unconvinced.
According to Li, officials told him that “a panel of experts” would begin investigating the reports from Gansu. But when he called the province’s health agency, it denied knowing about the cases and insisted that no such reports made it there. “I dare say they didn’t do any verification, but only went through the motions,” he said. The Gansu resident added: “Information [about the post-vaccination leukemia] gets blocked the instant we try to post something online. You can’t send it out.”
Li cited one such instance of censorship, when he proposed to the WeChat group that they bring up their predicament to the central government. This attracted the authorities’ attention, which led to the group’s disbandment.
“The police called us one by one. They said we have made things up, and ordered us to withdraw from the chat group.”
Visit VaccineDamage.news to read more stories about vaccine injuries and deaths.
Watch the video about an African woman injured by the Sinovac COVID-19 vaccine below.
This video is from the Puretrauma357 channel on Brighteon.com.
(Article by Ramon Tomey republished from citizens.news)
